Purinoceptors (P2X-receptor isoforms)

By Zidek W.   Tepel M.   Schluter H.   van der Giet M.   Jankowski J.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 101-103

Informa Healthcare

Access to resources Recommend Favorite

How should P 2X purinoceptors be classified pharmacologically?

By Kennedy C.   Leff P.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 5, 1995-05 ,pp. : 168-174

Elsevier

Access to resources Recommend Favorite

Effects of , -Unsaturated Sulphones and Phosphonium Salts on Ecto-ATPase Activity and Contractile Responses Mediated via P 2x -Purinoceptors

By Ziganshin A.U.   Berdnikov E.A.   Ziganshina L.E.   Tantasheva F.R.   Hoyle C.H.V.   Burnstock G.  

General Pharmacology, Vol. 26, Iss. 3, 1995-05 ,pp. : 527-532

Elsevier

Access to resources Recommend Favorite

Neuromodulator role of zinc and copper during prolonged ATP applications to P2X 4 purinoceptors

By Coddou C.   Morales B.   Huidobro-Toro J.P.  

European Journal of Pharmacology, Vol. 472, Iss. 1, 2003-07 ,pp. : 49-56

Elsevier

Access to resources Recommend Favorite

Protein kinase C &unknown;-dependent pathway of extracellular signal-regulated protein kinase activation by P2Y 1 and P2Y 2 purinoceptors that activate cytosolic phospholipase A 2 in endothelial cells

By Chen B.-C.   Lin L.-L.   Lin W.-W.  

European Journal of Pharmacology, Vol. 373, Iss. 1, 1999-05 ,pp. : 101-110

Elsevier

Access to resources Recommend Favorite